Portal Vein Thrombosis in Cirrhosis

Michael Loudin, Joseph Ahn

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Portal vein thrombosis (PVT) in the cirrhotic population is a challenging clinical phenomenon requiring a nuanced management approach. Uncertainty exists regarding the clinical significance of PVT in the cirrhotic population because the data for PVT are based mainly on retrospective, small cohort studies. Therefore, strong recommendations regarding the optimal timing, modality, and duration of therapy for PVT in the cirrhotic population cannot be made. However, this review aims to summarize the current literature and provide stepwise guidance in diagnosing and managing PVT in patients with cirrhosis.

Original languageEnglish (US)
Pages (from-to)579-585
Number of pages7
JournalJournal of Clinical Gastroenterology
Volume51
Issue number7
DOIs
StatePublished - 2017

Fingerprint

Portal Vein
Thrombosis
Fibrosis
Population
Uncertainty
Cohort Studies
Therapeutics

Keywords

  • anticoagulation
  • cirrhosis
  • direct acting oral anticoagulants
  • liver transplantation
  • low-molecular-weight heparin
  • portal vein thrombosis
  • Vitamin K antagonist

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Portal Vein Thrombosis in Cirrhosis. / Loudin, Michael; Ahn, Joseph.

In: Journal of Clinical Gastroenterology, Vol. 51, No. 7, 2017, p. 579-585.

Research output: Contribution to journalReview article

Loudin, Michael ; Ahn, Joseph. / Portal Vein Thrombosis in Cirrhosis. In: Journal of Clinical Gastroenterology. 2017 ; Vol. 51, No. 7. pp. 579-585.
@article{f6b63af1e3e747cdad047c9984a5447d,
title = "Portal Vein Thrombosis in Cirrhosis",
abstract = "Portal vein thrombosis (PVT) in the cirrhotic population is a challenging clinical phenomenon requiring a nuanced management approach. Uncertainty exists regarding the clinical significance of PVT in the cirrhotic population because the data for PVT are based mainly on retrospective, small cohort studies. Therefore, strong recommendations regarding the optimal timing, modality, and duration of therapy for PVT in the cirrhotic population cannot be made. However, this review aims to summarize the current literature and provide stepwise guidance in diagnosing and managing PVT in patients with cirrhosis.",
keywords = "anticoagulation, cirrhosis, direct acting oral anticoagulants, liver transplantation, low-molecular-weight heparin, portal vein thrombosis, Vitamin K antagonist",
author = "Michael Loudin and Joseph Ahn",
year = "2017",
doi = "10.1097/MCG.0000000000000834",
language = "English (US)",
volume = "51",
pages = "579--585",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Portal Vein Thrombosis in Cirrhosis

AU - Loudin, Michael

AU - Ahn, Joseph

PY - 2017

Y1 - 2017

N2 - Portal vein thrombosis (PVT) in the cirrhotic population is a challenging clinical phenomenon requiring a nuanced management approach. Uncertainty exists regarding the clinical significance of PVT in the cirrhotic population because the data for PVT are based mainly on retrospective, small cohort studies. Therefore, strong recommendations regarding the optimal timing, modality, and duration of therapy for PVT in the cirrhotic population cannot be made. However, this review aims to summarize the current literature and provide stepwise guidance in diagnosing and managing PVT in patients with cirrhosis.

AB - Portal vein thrombosis (PVT) in the cirrhotic population is a challenging clinical phenomenon requiring a nuanced management approach. Uncertainty exists regarding the clinical significance of PVT in the cirrhotic population because the data for PVT are based mainly on retrospective, small cohort studies. Therefore, strong recommendations regarding the optimal timing, modality, and duration of therapy for PVT in the cirrhotic population cannot be made. However, this review aims to summarize the current literature and provide stepwise guidance in diagnosing and managing PVT in patients with cirrhosis.

KW - anticoagulation

KW - cirrhosis

KW - direct acting oral anticoagulants

KW - liver transplantation

KW - low-molecular-weight heparin

KW - portal vein thrombosis

KW - Vitamin K antagonist

UR - http://www.scopus.com/inward/record.url?scp=85022068577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022068577&partnerID=8YFLogxK

U2 - 10.1097/MCG.0000000000000834

DO - 10.1097/MCG.0000000000000834

M3 - Review article

VL - 51

SP - 579

EP - 585

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 7

ER -